HomeIMVT • NASDAQ
add
Immunovant Inc
Previous close
$22.71
Day range
$22.29 - $23.31
Year range
$12.72 - $29.49
Market cap
4.02B USD
Avg Volume
1.66M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 131.76M | 13.84% |
Net income | -126.50M | -15.93% |
Net profit margin | — | — |
Earnings per share | -0.65 | 12.41% |
EBITDA | -131.66M | -13.84% |
Effective tax rate | -0.47% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 521.87M | 10.35% |
Total assets | 582.96M | 13.04% |
Total liabilities | 63.25M | -5.10% |
Total equity | 519.70M | — |
Shares outstanding | 175.28M | — |
Price to book | 7.62 | — |
Return on assets | -52.94% | — |
Return on capital | -58.39% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -126.50M | -15.93% |
Cash from operations | -102.52M | -15.64% |
Cash from investing | — | — |
Cash from financing | 24.60M | 3,269.18% |
Net change in cash | -77.04M | 11.51% |
Free cash flow | -57.53M | -32.28% |
About
Founded
2018
Website
Employees
362
